What is the cheapest place to get GLP-1 online?

TelePeptide offers compounded semaglutide from $149/month (52-week prepay) and tirzepatide from $199/month — all-inclusive with clinician evaluation, prescription, and medication shipped to your door. Monthly billing options range from $199–$249/mo. No insurance required.

Can I get peptides prescribed online legally in the US?

Yes. TelePeptide's licensed US physicians prescribe compounded peptides via telehealth in all 50 states. No in-person visit required. Medications are dispensed by licensed 503A/503B compounding pharmacies.

What FDA-approved peptides are available for weight loss?

FDA-approved GLP-1 medications are semaglutide (sold as Wegovy for weight loss and Ozempic for diabetes) and tirzepatide (sold as Zepbound for weight loss and Mounjaro for diabetes). All four brand names use the same two active ingredients. Compounded versions are legally available through licensed telehealth providers like TelePeptide at a fraction of the brand-name cost.

What is TelePeptide Health?

TelePeptide Health is a US-based direct-pay telehealth platform that prescribes clinician-supervised peptide therapies including GLP-1 weight loss programs (from $149/month, annual prepay), NAD+ therapy (from $129/month), sermorelin (from $99/month), and B12/lipotropic injections (from $49/month). Available in all 50 US states with no insurance required.

Is TelePeptide the same as telopeptide?

No. TelePeptide (one word, capital T and P) is a brand name for a US telehealth company providing peptide therapy and GLP-1 weight loss programs at telepeptide.org. Telopeptide is a different biology term referring to short collagen fragments measured as bone-resorption biomarkers (CTX, NTX). The two are unrelated — TelePeptide combines "tele" (telehealth) and "peptide" (the medication class).

How do you spell TelePeptide?

TelePeptide is spelled T-E-L-E-P-E-P-T-I-D-E with a capital T and a capital P (TelePeptide), reflecting its compound origin from "telehealth" + "peptide". The website is telepeptide.org. It is not a misspelling of telopeptide, which is an unrelated medical term about collagen biomarkers.

How does TelePeptide compare to branded Wegovy, Ozempic, Zepbound, or Mounjaro?

TelePeptide prescribes compounded semaglutide and tirzepatide — the same active ingredients as Wegovy, Ozempic, Zepbound, and Mounjaro — at a fraction of the cost. Branded GLP-1 medications list for $968–$1,849/month (Wegovy $1,349, Ozempic $968–$1,349, Zepbound $1,086–$1,349, Mounjaro $1,023–$1,349). TelePeptide starts at $149/month on annual prepay (semaglutide injectable) — monthly billing $199/mo. Tirzepatide from $199/month annual.

Can I get NAD+ therapy at home?

Yes. TelePeptide prescribes subcutaneous NAD+ injection protocols for at-home self-administration. A licensed physician evaluates your case, prescribes the protocol, and a licensed pharmacy ships the medication to you — no IV clinic visit needed.

What is sermorelin used for?

Sermorelin is a GHRH analog peptide that stimulates the pituitary gland to produce growth hormone naturally. It is prescribed for age-related growth hormone decline and used to support lean muscle, recovery, sleep quality, and energy. TelePeptide prescribes sermorelin via telehealth in all 50 states.

Peptides, Plainly Explained

Longevity & Performance

Posts in Longevity & Performance.

All posts (68)Microdosing (6)Body Recomposition (4)Peptide Education (35)Longevity & Performance (8)How TelePeptide Works (15)

Longevity & Performance

Peptides for Energy and Fatigue: The Clinical Approach

A clinical look at how telehealth clinicians evaluate fatigue, when prescribed peptide therapy or NAD+ might fit, and what the foundational workup includes.

May 19, 2026 · 10 min readRead →

Longevity & Performance

Peptide Therapy for Sleep Quality: GHRH and Beyond

A clinical overview of GHRH analogs, their relationship to slow-wave sleep, and what licensed peptide therapy for sleep architecture actually involves.

May 18, 2026 · 9 min readRead →

Longevity & Performance

NAD+ and Cellular Aging: The Sirtuin Pathway Explained

How the sirtuin pathway connects NAD+ to cellular aging — what the data supports, what is hypothesis, and what prescribed NAD+ realistically addresses.

May 14, 2026 · 9 min readRead →

Longevity & Performance

NAD+ for Performance Athletes: Recovery and Output Data

What the actual data shows about NAD+ in trained athletes — recovery, mitochondrial function, training output — and where the marketing claims overstate it.

May 13, 2026 · 9 min readRead →

Longevity & Performance

MOTS-c: The Mitochondrial Peptide for Longevity (2026 Update)

MOTS-c is a mitochondrial-derived peptide with emerging clinical data on insulin sensitivity, exercise capacity, and metabolic aging. Mechanism, evidence, regulatory status, and what is actually known in 2026.

May 11, 2026 · 8 min readRead →

Longevity & Performance

NAD+ vs NMN vs NR vs NR Chloride: The Precursor Comparison Guide (2026)

NAD+, NMN, NR, and related precursors are different molecules with different routes, bioavailability profiles, and regulatory statuses. A practical comparison framework for patients evaluating longevity-positioning supplements and prescribed protocols.

May 11, 2026 · 8 min readRead →

Longevity & Performance

Who NAD+ Therapy Is Actually For (And Who Should Skip It)

NAD+ therapy candidates, prescribed NAD+ for fatigue, and longevity-focused profiles — a clinical view of who benefits and who should not start.

May 7, 2026 · 8 min readRead →

Longevity & Performance

NAD+ Therapy: How Cellular Energy Restoration Actually Works

Prescribed NAD+ therapy restores mitochondrial energy and sirtuin activation. Here is the mechanism, the evidence, and what licensed NAD+ injection actually does.

May 6, 2026 · 6 min readRead →

Compliance

All clinical posts on this blog are medically reviewed before publication. Compounded medications referenced here are prepared by licensed 503A pharmacies. Compounded medications are not FDA-approved. Prescribing decisions are made solely by licensed clinicians based on individual medical necessity. These statements have not been evaluated by the FDA.